134 related articles for article (PubMed ID: 9075806)
1. Aldose reductase inhibition increases CNTF-like bioactivity and protein in sciatic nerves from galactose-fed and normal rats.
Mizisin AP; Calcutt NA; DiStefano PS; Acheson A; Longo FM
Diabetes; 1997 Apr; 46(4):647-52. PubMed ID: 9075806
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effects of aldose reductase inhibitor on experimental diabetic neuropathy through synthesis/secretion of nerve growth factor.
Ohi T; Saita K; Furukawa S; Ohta M; Hayashi K; Matsukura S
Exp Neurol; 1998 Jun; 151(2):215-20. PubMed ID: 9628756
[TBL] [Abstract][Full Text] [Related]
3. Schwann cell injury is attenuated by aldose reductase inhibition in galactose intoxication.
Mizisin AP; Powell HC
J Neuropathol Exp Neurol; 1993 Jan; 52(1):78-86. PubMed ID: 8426189
[TBL] [Abstract][Full Text] [Related]
4. Schwann cell changes induced as early as one week after galactose intoxication.
Mizisin AP; Powell HC
Acta Neuropathol; 1997 Jun; 93(6):611-8. PubMed ID: 9194901
[TBL] [Abstract][Full Text] [Related]
5. BDNF attenuates functional and structural disorders in nerves of galactose-fed rats.
Mizisin AP; Bache M; DiStefano PS; Acheson A; Lindsay RM; Calcutt NA
J Neuropathol Exp Neurol; 1997 Dec; 56(12):1290-301. PubMed ID: 9413278
[TBL] [Abstract][Full Text] [Related]
6. Nerve conduction velocity and axonal transport of 6-phosphofructokinase activity in galactose-fed rats.
Willars GB; Calcutt NA; Tomlinson DR
J Neurol Sci; 1991 Jul; 104(1):46-51. PubMed ID: 1717661
[TBL] [Abstract][Full Text] [Related]
7. Coexistence of nerve conduction deficit with increased Na(+)-K(+)-ATPase activity in galactose-fed mice. Implications for polyol pathway and diabetic neuropathy.
Calcutt NA; Tomlinson DR; Biswas S
Diabetes; 1990 Jun; 39(6):663-6. PubMed ID: 2161366
[TBL] [Abstract][Full Text] [Related]
8. Decreased endoneurial fluid electrolytes in normal rat sciatic nerve after aldose reductase inhibition.
Mizisin AP; Kalichman MW; Calcutt NA; Myers RR; Powell HC
J Neurol Sci; 1993 May; 116(1):67-72. PubMed ID: 8389817
[TBL] [Abstract][Full Text] [Related]
9. Galactosemia produces ARI-preventable nodal changes similar to those of diabetic neuropathy.
Kamijo M; Basso M; Cherian PV; Hohman TC; Sima AA
Diabetes Res Clin Pract; 1994 Sep; 25(2):117-29. PubMed ID: 7821191
[TBL] [Abstract][Full Text] [Related]
10. An aldose reductase inhibitor and aminoguanidine prevent vascular endothelial growth factor expression in rats with long-term galactosemia.
Frank RN; Amin R; Kennedy A; Hohman TC
Arch Ophthalmol; 1997 Aug; 115(8):1036-47. PubMed ID: 9258227
[TBL] [Abstract][Full Text] [Related]
11. Dissociation between biochemical and functional effects of the aldose reductase inhibitor, ponalrestat, on peripheral nerve in diabetic rats.
Cameron NE; Cotter MA
Br J Pharmacol; 1992 Dec; 107(4):939-44. PubMed ID: 1467842
[TBL] [Abstract][Full Text] [Related]
12. NT-3 attenuates functional and structural disorders in sensory nerves of galactose-fed rats.
Mizisin AP; Kalichman MW; Bache M; Dines KC; DiStefano PS
J Neuropathol Exp Neurol; 1998 Sep; 57(9):803-13. PubMed ID: 9737543
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and localization of ciliary neurotrophic factor in the sciatic nerve of the adult rat after lesion and during regeneration.
Sendtner M; Stöckli KA; Thoenen H
J Cell Biol; 1992 Jul; 118(1):139-48. PubMed ID: 1618901
[TBL] [Abstract][Full Text] [Related]
14. Reduced ciliary neuronotrophic factor-like activity in nerves from diabetic or galactose-fed rats.
Calcutt NA; Muir D; Powell HC; Mizisin AP
Brain Res; 1992 Mar; 575(2):320-4. PubMed ID: 1571789
[TBL] [Abstract][Full Text] [Related]
15. Ciliary neurotrophic factor improves nerve conduction and ameliorates regeneration deficits in diabetic rats.
Mizisin AP; Vu Y; Shuff M; Calcutt NA
Diabetes; 2004 Jul; 53(7):1807-12. PubMed ID: 15220205
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of macrophage chemotaxis and peripheral nerve regeneration in normal and hyperglycemic rats by the aldose reductase inhibitor Tolrestat.
Calcutt NA; McMurray HF; Moorhouse DF; Bache M; Parthasarathy S; Powell HC; Mizisin AP
Exp Neurol; 1994 Aug; 128(2):226-32. PubMed ID: 8076666
[TBL] [Abstract][Full Text] [Related]
17. Cellular pathology of the nerve microenvironment in galactose intoxication.
Forcier NJ; Mizisin AP; Rimmer MA; Powell HC
J Neuropathol Exp Neurol; 1991 May; 50(3):235-55. PubMed ID: 2022966
[TBL] [Abstract][Full Text] [Related]
18. Elevated lipid peroxidation and DNA oxidation in nerve from diabetic rats: effects of aldose reductase inhibition, insulin, and neurotrophic factors.
Cunha JM; Jolivalt CG; Ramos KM; Gregory JA; Calcutt NA; Mizisin AP
Metabolism; 2008 Jul; 57(7):873-81. PubMed ID: 18555826
[TBL] [Abstract][Full Text] [Related]
19. Aldose reductase inhibition, Doppler flux and conduction in diabetic rat nerve.
Calcutt NA; Mizisin AP; Kalichman MW
Eur J Pharmacol; 1994 Jan; 251(1):27-33. PubMed ID: 8137868
[TBL] [Abstract][Full Text] [Related]
20. Adenosine triphosphatase in nerves and ganglia of rats with streptozotocin-induced diabetes or galactosaemia; effects of aldose reductase inhibition.
Lambourne JE; Brown AM; Calcutt N; Tomlinson DR; Willars GB
Diabetologia; 1988 Jun; 31(6):379-84. PubMed ID: 2970984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
